Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Ipsen’s Iqirvo accepted by SMC to treat rare liver disease primary biliary cholangitis

The life-long condition affects approximately 1,900 people in Scotland

- PMLiVE

Naturally occurring peptide shows promise as potential psoriasis treatment

The approach could reduce disease severity with fewer side effects than conventional treatments

Smart-Works-Leeds-Office

Digital agency, Mednet, supporting women back into work

Mednet, a digital marketing and brand partner in Pharma, has recently strengthened its partnership with women’s charity Smart Works Leeds by donating fully-wiped and refurbished laptops to support the charity’s...

Mednet

- PMLiVE

GSK and ABL Bio enter neurodegenerative disease agreement worth over £2bn

The licensing deal will give GSK access to ABL Bio's blood-brain barrier shuttle platform

- PMLiVE

AstraZeneca’s Imfinzi regimen receives EC approval to treat resectable NSCLC

More than 450,000 people are diagnosed with lung cancer every year in Europe

- PMLiVE

J&J’s Stelara granted EC approval to treat Crohn’s disease in paediatric patients

Approximately 25% of cases are diagnosed during childhood or adolescence

- PMLiVE

The AI advantage: seven steps to augmented pharma brand planning

By strategically leveraging AI, teams can work smarter and more efficiently

- PMLiVE

From Noise to Impact: Why Simplicity Is The Health Communicator’s Most Powerful Tool

Clear health communication has never been more critical, as shown by the 2025 surge in ADHD self-diagnoses in the UK, driven by misleading social media content. In a noisy, fast-paced...

Fox&Cat

- PMLiVE

Amgen’s Uplizna approved by FDA as first treatment for rare disease IgG4-RD

Immunoglobulin G4-related disease affects approximately 20,000 people in the US

- PMLiVE

Novartis’ Vanrafia granted FDA approval for rare kidney disease IgA nephropathy

Almost 13 out of every million people in the US are diagnosed with IgAN each year

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu receives EC approval for HER2-low breast cancer

Approximately 557,000 people are diagnosed with breast cancer every year in Europe

- PMLiVE

The importance of the human touch in today’s AI world

The robots aren’t taking over – but they do have the potential to elevate our profession

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links